Go to deals
Healthcare | TMT

p-value Group has been acquired by Publicis Groupe

p-value Group, one of the largest independent medical communications agencies in North America, has been acquired by Publicis Groupe (ENXTPA:PUB) for its strong strategic fit, global scale and cultural alignment. The acquisition enhances Publicis Groupe’s medical communications capabilities in the USA and supports its broader strategy of integrating science-first solutions across its global network.

Founded in 2004 by Linda Corvari, p-value is a leading full-service provider of medical and scientific communications, serving marquee clients across the life sciences sector. The company specializes in medical strategy, scientific communications, content development and speaker bureau management, earning a strong reputation for scientific rigor, exceptional client service and a culture of excellence. p-value maintains diverse and expanding expertise across therapeutic areas, with particularly strong experience in dermatology.

Publicis Groupe, founded in 1926 and headquartered in Paris, France, is the world's second-largest advertising holding company by revenue. The group offers a broad range of services, including traditional and digital advertising, public relations and consulting. It employs approximately 108,000 people worldwide, with over 80% of its revenue generated from developed markets, particularly North America and Europe.

Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction, highlighting the team’s deep domain expertise in the pharmaceutical services sector and broader marketing agency landscape.

Parties

Talk to the deal team

Adam Abramowitz

Managing Director
Los Angeles, United States
Oaklins Intrepid

Greg Passani

Associate Director
Los Angeles, United States
Oaklins Intrepid

Ellie Taraska

Associate
Los Angeles, United States
Oaklins Intrepid

Related deals

NetNordic has acquired Itectra
TMT

NetNordic has acquired Itectra

Norvestor-backed NetNordic has acquired Danish optical network solutions firm Itectra. The transaction marks NetNordic’s 25th acquisition since 2015, further strengthening its position in the Nordic market. It enables NetNordic to expand its market relevance through deeper expertise in optical network solutions, consolidating its standing in larger Nordic projects and creating cross-selling opportunities between NetNordic’s network solutions and Itectra’s optical capabilities.

Learn more
Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Healthcare

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Learn more
Matera has acquired a majority stake in Fáciltech
Private Equity | TMT

Matera has acquired a majority stake in Fáciltech

Matera has acquired a controlling stake in Fáciltech. The acquisition represents a strategic step to expand Matera’s client base and strengthen its core banking offering, incorporating specialized operational management and ERP solutions that serve institutions with different profiles and business models.

Learn more